Concepedia

Suzana Vega Harring

SV

Statistics

Publications

5

Citations

123

H-Index

5

Active since

2013

Affiliations

Roche Pharma AG (Germany)(Current)

Roche (Switzerland)

La Roche College

Roche (United States)

Suzana Vega Harring is an author at Roche Pharma AG (Germany) specializing in oncology, cancer biomarkers, and cancer immunotherapy.

Publications per year

2013–2024

5

Publications

5

Antibody mediated CDCP1 degradation as mode of action for cancer targeted therapy

Gwendlyn Kollmorgen, Gerhard Niederfellner, Alexander Lifke et al. · Molecular Oncology · 2013 · 38 citations · Full text

Life Sciences, Cell Biology, Oncology +15

Comprehensive analysis of fibroblast activation protein expression across 23 tumor indications: insights for biomarker development in cancer immunotherapies

Sebastian Dziadek, Anton Kraxner, Wei‐Yi Cheng et al. · Frontiers in Immunology · 2024 · 33 citations · Full text

Medicine, Cancer Biology, Oncology +17

Determination of phosphorylated proteins in tissue specimens requires high‐quality samples collected under stringent conditions

Corinna M. Wolf, Tiantom Jarutat, Suzana Vega Harring et al. · Histopathology · 2013 · 19 citations

Medicine, Oncology, Pathology +16

Vanucizumab mode of action: Serial biomarkers in plasma, tumor, and skin-wound-healing biopsies

Florian Heil, Galina Babitzki, Alice Julien-Laferrière et al. · Translational Oncology · 2020 · 18 citations · Full text

Medicine, Oncology, Pharmacology +17

Investigating the complex interplay between fibroblast activation protein α-positive cancer associated fibroblasts and the tumor microenvironment in the context of cancer immunotherapy

Anton Kraxner, Franziska Braun, Wei‐Yi Cheng et al. · Frontiers in Immunology · 2024 · 15 citations · Full text

Medicine, Cancer Biology, Oncology +17

1–5 of 5